Skip to content
o2h discovery logo

o2h discovery website

o2h discovery – seeding new ideas in life science, tech and green …

o2h discovery logo
  • about
    • company overview
    • team
    • ESG
    • o2h community
  • how we deliver
  • news & insights
    • news & press releases
    • blogs
    • posters
    • newsletters
    • white papers
  • events
    • exhibiting/attending events
    • o2h Innovation Conference 2025
    • Bootcamps
    • AIM squad
    • Cambridge Wide Open Day
    • Cambridge TechBIO Caucus
    • Biotech Bikers
    • o2h Chaitime Webinar
  • culture & careers
  • CITCTM
  • o2h group
  • integrated(drug discovery)
    • Target Identification and Validation
    • Hit Identification
    • Hit to Lead
    • Lead Optimization
    • Targeted protein degradation
    • Fragment-based Drug Discovery
    • Knowledge-based drug design and SAR
    • Early assessment of in vitro ADMET and PK
  • chemistry
    • Medicinal Chemistry Services
    • synthetic chemistry
    • peptide synthesis service
    • PROTAC Services
    • Lipid Nanoparticles (LNPs)
    • analytical chemistry
    • ADCs – linker/payloads
    • catalog
  • biology
    • target engagement and validation
      • PROTAC
      • NanoBRET/NanoBiT
      • NaLTSA
      • CRISPR/Cas9
      • siRNA/shRNA
      • Undruggable targets and genetic benchmarking
    • Assay biology
      • Biophysical
      • Biochemical
      • Cellular
      • Gene expression
      • Drug-Drug interactions and synthetic lethality
      • Biomarker assessment
      • Site-directed mutagenesis & binding studies
    • Drug Screening
      • Iterative screening
      • Primary, orthogonal and selectivity
      • Fragment-based screening
      • Phenotypic screening
    • Biology Insights
      • Biochemistry
      • RNA Binding Small Molecule
      • High-Content Imaging
      • Immuno-Oncology Therapeutics
      • Psychedelics
      • Read more…
  • DMPK
    • in-vitro ADME
      • ChamelogK Assay
    • in-vivo Pharmacokinetics (PK)
  • scale-up
    • kilo-lab
    • non-GMP
    • GMP [partnership]
  • models
    • o2h Kickstarter: Global
    • o2h Kickstarter Japan
    • o2h Biology Match Funding
    • o2h Plug-in Biotech
    • o2h Peptide Guarantee
    • o2h Kickstarter: Innovate America
    • o2h discovery Inflexion Tx
    • o2h Platinum Partner
    • o2h Fast Pharma 18
    • Power Your Pipeline With India
  • contact
o2h Kickstarter Japan - Live Now! A New Opportunity for Japanese Biotech Start-ups
View this email in your browser

o2h Discovery is back working in Japan in full throttle; our past collaborations have included the largest pharmaceutical companies in Japan. In order to show our support for the Japanese Biotech ecosystem, we are launching the ‘o2h Kickstarter: Japan’ Edition. This recently launched edition is designed exclusively to support Japanese start-ups in accelerating their discovery journeys and achieving their next R&D milestones.

Should you wish to accelerate your chemistry project as an early-stage biotech leader, our program is now open for applications. Please review your eligibility and apply through the link below. We look forward to supporting you in advancing your discovery pipeline. If you’re not the right person to receive this, please feel free to forward it to someone in your team or network who could benefit from the award.

Hemal Soni, Head of Chemistry and I will be in Tokyo for BioJapan from Oct 6th-10th, and we’re open to meetings.


Kind regards,
Sunil Shah
Co-Founder, o2h Discovery

About the o2h Kickstarter: Japan

Supporting Japanese Early-Stage Biotechs with Chemistry Expertise
With the o2h Kickstarter: Japan edition, we are honoured to extend this exciting opportunity exclusively to Japanese biotech start-ups that have secured initial funding and are seeking to accelerate their research to reach the next milestone.

Selected start-ups will gain access to a dedicated team of chemists and project management support to generate high-quality chemical matter aligned with their scientific goals. Check our recent LinkedIn post.

Benefits of Winning the Kickstarter Award

Register your interest

Overview

Since its inception in 2022, the o2h Kickstarter has completed 7+ editions and has supported more than 30 biotech start-ups worldwide (UK, Australia, Israel, Italy, and USA), enabling early-stage ventures to advance their pipelines more efficiently and cost-effectively.

We understand that navigating early-stage biotech funding can be challenging, especially for start-ups securing their first investment and generating critical seed data. While some raise substantial funding early, many have found real value in the o2h Kickstarter Award, helping portfolio companies progress into larger rounds.

o2h Discovery, established in 2003, is a fully integrated Anglo-Indian CRO with a 750+ strong team across Cambridge, UK, and Ahmedabad, India, supporting small molecule synthesis, PR&D, and scale-up. We execute hit-to-lead optimization programs, enabling patent and IND filings, with expertise spanning discovery chemistry, biology, DMPK, and end-to-end preclinical project management.


👉 [Read the full press release here]

Some of Our Previous Edition Winners

From concept to chemistry breakthroughs, hear directly from our winners…
These stories show what’s possible with the right support. If you’re ready to be part of this transformative journey in Japanese biotech, we encourage you to submit your application and kickstart your discovery pipeline. It's a time-limited competition designed exclusively for Japanese biotech start-ups. So don't miss the opportunity.
Yes! I want to submit my application
Meet Us at BioJapan

Heading to BioJapan? Get a chance to connect with Sunil Shah (Co-Founder), Hemal Soni (VP, Head of Chemistry), from Oct 6th-10th, and learn more about Kickstarter Japan to accelerate your drug discovery programs. 📧 To schedule a meeting, email us at discovery@o2h.com.

If you know someone in your biotech network who could benefit, we’d be grateful if you could share this email with them.

Forward to a biotech friend Forward to a biotech friend
Copyright © 2025 o2h group, All rights reserved.
You are connected with o2h discovery with regards to chemistry and biology services and related..

Our mailing address is:
o2h group
The Mill Scitech Park, Hauxton House
Mill Lane, Hauxton
Cambridge, Cambridgeshire CB22 5HX
United Kingdom

Want to change how you receive these emails?
You can
update your preferences or unsubscribe from this list.
logo-img

o2h discovery private limited.

  • about

    • company overview
    • team
    • culture
    • ESG
  • services

    • Integrated Drug Discovery
    • Fragment-based Drug Discovery
    • Chemistry
    • In-vitro ADME
  • other links

    • news and insights
    • Events
    • o2h community
    • contact
Visit o2h.com o2h discovery
  • social_media_icons
  • social_media_icons
  • social_media_icons
  • social_media_icons

Copyright ©   All rights reserved.

cookies policy privacy policy